These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12142644)

  • 21. [Benzodiazepine poisoning in a neonate: clinical and toxicokinetic evaluation following enterodialysis with activated charcoal].
    Malgorn G; Leboucher B; Harry P; Turcant A; Catala L; Giniès JL
    Arch Pediatr; 2004 Jul; 11(7):819-21. PubMed ID: 15234378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paroxetine: an update of its use in psychiatric disorders in adults.
    Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
    Drugs; 2002; 62(4):655-703. PubMed ID: 11893234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamics and persistence of CYP2D6 inhibition by paroxetine.
    Juřica J; Žourková A
    J Clin Pharm Ther; 2013 Aug; 38(4):294-300. PubMed ID: 23437966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder.
    Hori H; Yoshimura R; Ueda N; Ikenouchi-Sugita A; Umene-Nakano W; Nakamura J
    World J Biol Psychiatry; 2009; 10(4 Pt 2):620-2. PubMed ID: 18609433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacokinetic studies on interactions between dipotassium clorazepate and alcohol after oral application (author's transl)].
    Staak M; Moosmayer A
    Arzneimittelforschung; 1978; 28(7):1187-91. PubMed ID: 39573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the serotonin 1A, 2A, 2C, 3A, and 3B and serotonin transporter gene polymorphisms on the occurrence of paroxetine discontinuation syndrome.
    Murata Y; Kobayashi D; Imuta N; Haraguchi K; Ieiri I; Nishimura R; Koyama S; Mine K
    J Clin Psychopharmacol; 2010 Feb; 30(1):11-7. PubMed ID: 20075642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baseline anxiety effect on outcome of SSRI treatment in patients with severe depression: escitalopram vs paroxetine.
    Boulenger JP; Hermes A; Huusom AK; Weiller E
    Curr Med Res Opin; 2010 Mar; 26(3):605-14. PubMed ID: 20067433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clorazepate dipotassium.
    Bartenbach DE
    Am Fam Physician; 1978 Oct; 18(4):43,46,50. PubMed ID: 30272
    [No Abstract]   [Full Text] [Related]  

  • 29. Halazepam, another precursor of desmethyldiazepam.
    Greenblatt DJ; Locniskar A; Shader RI
    Lancet; 1982 Jun; 1(8285):1358-9. PubMed ID: 6123659
    [No Abstract]   [Full Text] [Related]  

  • 30. Steady-state bioavailability of two clorazepate dipotassium dosage forms.
    Carrigan PJ; Chao GC; Barker WM; Hoffman DJ; Chun AH
    J Clin Pharmacol; 1977 Jan; 17(1):18-28. PubMed ID: 13089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quadricyclic antidepressant overdosage in a patient with AIDS under mega-highly active antiretroviral therapy.
    Hocqueloux L; Gallien S; Bornstain C; Molina JM
    Arch Intern Med; 2001 Oct; 161(18):2260-1. PubMed ID: 11575985
    [No Abstract]   [Full Text] [Related]  

  • 32. Paroxetine-induced conversion of cytochrome P450 2D6 phenotype and occurence of adverse effects.
    Zourková A; Hadasová E
    Gen Physiol Biophys; 2003 Mar; 22(1):103-13. PubMed ID: 12870705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in the oral absorption characteristics in man of dipotassium clorazepate at normal and elevated gastric pH.
    Abruzzo CW; Macasieb T; Weinfeld R; Rider JA; Kaplan SA
    J Pharmacokinet Biopharm; 1977 Aug; 5(4):377-90. PubMed ID: 19611
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetic fluvoxamine-clomipramine interaction with favorable therapeutic consequences in therapy-resistant depressive patient.
    Conus P; Bondolfi G; Eap CB; Macciardi F; Baumann P
    Pharmacopsychiatry; 1996 May; 29(3):108-10. PubMed ID: 8738315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No effect of the new antidepressant reboxetine on CYP2D6 activity in healthy volunteers.
    Avenoso A; Facciolà G; Scordo MG; Spina E
    Ther Drug Monit; 1999 Oct; 21(5):577-9. PubMed ID: 10519458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An uncommon fatality due to moclobemide and paroxetine.
    Singer PP; Jones GR
    J Anal Toxicol; 1997 Oct; 21(6):518-20. PubMed ID: 9323537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An autopsy case of poisoning with selective serotonin reuptake inhibitor, paroxetine.
    Motonori T; Hiroshi K; Azumi K; Mai M; Minori N; Harumi O; Takako M; Kiyoshi M; Takehiko Y; Hiroyuki M; Nao O; Shie Y; Nobuyuki A; Yasuhiro U; Shigeru H; Hajime N
    Soud Lek; 2010 Jan; 55(1):2-4. PubMed ID: 21275227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mixed benzodiazepine poisoning and reversal with flumazenil (Ro 15-1788)].
    Rivas López FA; López Soriano F; Mendoza Cerezo A; Jiménez Ferré J; Azurmendi Rodríguez JI; de la Rubia Nieto MA
    Rev Esp Anestesiol Reanim; 1989; 36(1):48-50. PubMed ID: 2565591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steady-state plasma desmethyldiazepam during long-term clorazepate use: effects of antacids.
    Shader RI; Ciraulo DA; Greenblatt DJ; Harmatz JS
    Clin Pharmacol Ther; 1982 Feb; 31(2):180-3. PubMed ID: 6120059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of CYP2D6 activity on the pharmacokinetics and pharmacodynamics of a single 20 mg dose of ibogaine in healthy volunteers.
    Glue P; Winter H; Garbe K; Jakobi H; Lyudin A; Lenagh-Glue Z; Hung CT
    J Clin Pharmacol; 2015 Jun; 55(6):680-7. PubMed ID: 25651476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.